We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
(+14%)
Cap. Flow
+$908M
Cap. Flow
% of AUM
14.82%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$85M |
| 2 |
Abbott
ABT
|
+$72M |
| 3 |
NVIDIA
NVDA
|
+$60.9M |
| 4 |
Teradyne
TER
|
+$52.2M |
| 5 |
Legend Biotech
LEGN
|
+$50.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$98.7M |
| 2 |
Texas Instruments
TXN
|
+$95.4M |
| 3 |
Global Payments
GPN
|
+$54.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$49.4M |
| 5 |
KLA
KLAC
|
+$49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.26% |
| 2 | Technology | 25.67% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 5.47% |
| 5 | Consumer Staples | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Ionis Pharmaceuticals
IONS
$9.1B
| $13.6M | 0.22% |
405,461
-558,327
| -58% | -$21M |
|
127
Dynatrace
DT
$13.2B
| $13.5M | 0.22% |
+190,287
| New | +$12.5M |
|
128
VeriSign
VRSN
$26.8B
| $13.3M | 0.22% |
+64,748
| New | +$14.2M |
|
|
HRC
129
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $13.1M | 0.21% |
+87,417
| New | +$11.8M |
|
130
Exelixis
EXEL
$14B
| $12.7M | 0.21% |
601,800
| – | – |
|
|
JNPR
131
DELISTED
Juniper Networks
JNPR
| $12.7M | 0.21% |
460,521
-233,734
| -34% | -$6.58M |
|
132
Spotify
SPOT
$103B
| $12.7M | 0.21% |
56,192
+13,110
| +30% | +$3.09M |
|
133
Stevanato
STVN
$5.34B
| $12.7M | 0.21% |
+500,000
| New | +$11.8M |
|
134
Ziff Davis
ZD
$2.01B
| $12.6M | 0.21% |
+106,474
| New | +$12.8M |
|
|
P
135
Everpure Inc
P
$28B
| $12.6M | 0.21% |
502,381
-640,770
| -56% | -$14.1M |
|
136
Zimmer Biomet
ZBH
$18.4B
| $12.6M | 0.21% |
+88,888
| New | +$13.1M |
|
137
Elastic
ESTC
$7.42B
| $12.6M | 0.21% |
+84,723
| New | +$13M |
|
|
ESMT
138
DELISTED
EngageSmart, Inc.
ESMT
| $12.3M | 0.2% |
+360,747
| New | +$12.4M |
|
|
CTLT
139
DELISTED
CATALENT, INC.
CTLT
| $12.2M | 0.2% |
91,807
+56,480
| +160% | +$7.05M |
|
|
PPD
140
DELISTED
PPD, Inc. Common Stock
PPD
| $12.2M | 0.2% |
+260,117
| New | +$12M |
|
|
ARNA
141
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $12.2M | 0.2% |
204,225
-216,728
| -51% | -$12.8M |
|
142
PMV Pharmaceuticals
PMVP
$60.3M
| $12.1M | 0.2% |
407,365
+168,284
| +70% | +$5.37M |
|
143
Pulmonx
LUNG
$87M
| $12.1M | 0.2% |
336,313
+40
| +0% | +$1.57K |
|
144
Constellation Brands
STZ
$22.4B
| $12.1M | 0.2% |
57,369
+5,418
| +10% | +$1.18M |
|
145
Clear Channel Outdoor Holdings
CCO
$1.23B
| $12.1M | 0.2% |
4,446,974
+1,052,986
| +31% | +$2.63M |
|
146
Visa
V
$686B
| $12M | 0.2% |
+53,800
| New | +$12.6M |
|
147
Infosys
INFY
$49.7B
| $11.8M | 0.19% |
+529,894
| New | +$12M |
|
148
Syndax Pharmaceuticals
SNDX
$1.71B
| $11.1M | 0.18% |
581,308
+373,496
| +180% | +$6.22M |
|
149
AtaiBeckley Inc
ATAI
$2.65B
| $11.1M | 0.18% |
750,019
-41,566
| -5% | -$676K |
|
150
Flex
FLEX
$46B
| $10.9M | 0.18% |
820,073
-70,177
| -8% | -$943K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.
- Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
- Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
- Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
- Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
- Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
- Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
- Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.
Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.